What is the main business of Mediguard?

The main business activity of Mediguard focuses on activities of head office and holding companies, excluding financial holding companies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 17, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Postępu 15C, 02-676 Warszawa.

Who is on the management board?

The management board consists of: Tomasz Maciej Kościelny (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 132,703 (approx. $35,846).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.

What revenue was generated?

The company reported a revenue of $119,654 in 2020, which is a decrease of 50.1% compared to 2019.

Is the company profitable?

No, in 2020 the company was not profitable, reporting a net loss of $49,987. For comparison, in 2019 the loss was $29,629, meaning the company increased its loss by 71.3%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $88,309 in 2020, representing 52% of all operating expenses.

MediguardS.A.

Activities of head office and holding companies, excluding financial holding companies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-01-17

Share capital

132 702,60 PLN

Activity description

Mediguard is a company that provides telemedicine services, allowing remote health monitoring and diagnostic consultations for patients. It offers a platform that integrates various diagnostic devices such as EKGs, blood pressure monitors, and glucometers, enabling patients to perform tests at home and consult with specialists. Additionally, Mediguard supplies telemedical kits and kiosks for healthcare facilities, facilitating efficient patient diagnostics and data management.

Registered address

ul. Postępu 15C, 02-676 Warszawa, Poland

Website

mediguard.pl

Financials

The financial statement for 2021 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue

This companyUSD 119.65kMedianUSD 24.36kAverageUSD 8.28m

Net profit

This companyUSD -49.99kMedianUSD 231.21AverageUSD 659.26k

Operating costs

This companyUSD 169.38kMedianUSD 10.68kAverageUSD 10.19m

Assets

This companyUSD 475.18kMedianUSD 79.65kAverageUSD 15.16m

Industry

Bank accounts

Registered as a VAT taxpayer on 2017-09-27. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
Feb 2, 2026	Dissolution without liquidation opened

Public aid

5 public aid cases recorded, with a total value of $368,030.

Grant date	Purpose	Gross amount	Granting body
Mar 16, 2022	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$1,402$1,402	Prezes Zakładu Ubezpieczeń Społecznych
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$902$902	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$902$902	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Authorized Representatives

Tomasz Maciej Kościelny — President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board acts independently; in the case of a multi-member management board, two members of the management board acting jointly, or a member of the management board together with a commercial proxy acting jointly.

Supervisory board

Andrzej Stachnik — Supervisory Board Member

Michał Piotr Chabowski — Supervisory Board Member

Krzysztof Piotr Czaplicki — Supervisory Board Member

Jacek Wiśniewski — Supervisory Board Member

Tomasz Teodor Kaniowski — Supervisory Board Member

Beneficial owners

Person	Rights
Michal Piotr Chabowski (37)	Właściciel 50% udziałów w rubicon partner holding sp.z o.o., w której 100% udziałów posiada rubicon partners corporate finanse s.a., w której 100% udziałów posiada rubicon partners ventures asi sp. z o.o., która posiada 25,90% w mg group s.a.
Grzegorz Józef Golec (51)	Właściciel 50% udziałów w rubicon partner holding sp.z o.o., w której 100% udziałów posiada rubicon partners corporate finanse s.a., w której 100% udziałów posiada rubicon partners ventures asi sp. z o.o., która posiada 25,90% w mg group s.a.
Tomasz Maciej Kościelny (53)	Właściciel 71,20% udziałów w mediguard sp. z o.o. która posiada 35,92% w mg group s.a.

Subsidiaries

	Name	Share value	Stake
	Mediguard Technologiessp. z o.o.	578,835.76 USD	100%
	Mediboxsp. z o.o.	2,701.24 USD	67.7966%

Competitors

Name	Revenue	Website
Medgzsp. z o.o.	$319,571.09	medgz.pl
Entrastsp. z o.o.	$102,543.54	entrast.pl
Amedar Consultingsp. z o.o.	$71,468.14	amedar.com

Change history

Date	Event
2022-12-07	Share capital change (111,351.30 PLN → 132,702.60 PLN)
2020-11-09	Address change (Ul. Żurawia 22/615, 00-515, Warszawa → Ul. Postępu 15c, 02-676, Warszawa)
2020-11-09	Name change (Mg Group → Mediguard)
2019-04-09	Address change (Ul. Emilii Plater 28, 00-688, Warszawa → Ul. Żurawia 22/615, 00-515, Warszawa)
2019-04-09	Share capital change (100,000.00 PLN → 111,351.30 PLN)

FAQ

Last updated: 2026-03-29